Life Sciences Tools and Services
Company Overview of Kalexsyn, Inc.
Kalexsyn, Inc., a contract research organization, provides medicinal chemistry services to the pharmaceutical industry. Its services include the conception and synthesis of new analogs for lead optimization, SAR expansion, and hit to lead transition. The company provides services in the areas of medicinal chemistry, and custom and stable label synthesis. It has strategic partnerships with Michigan High Throughput Screening Center; Ceetox, Inc.; PharmOptima, LLC; and Ash Stevens Inc. The company was founded in 2003 and is based in Kalamazoo, Michigan. As of May 17, 2018, Kalexsyn, Inc. operates as a subsidiary of Dipharma Inc..
4502 Campus Drive
Kalamazoo, MI 49008
Founded in 2003
Key Executives for Kalexsyn, Inc.
Kalexsyn, Inc. Key Developments
Similar Private Companies By Industry
|10X Genomics, Inc.||United States|
|4G Clinical, Inc.||United States|
|AAPharmaSyn LLC||United States|
|Abiant, Inc.||United States|
|aBioBot, Inc.||United States|
Recent Private Companies Transactions
April 23, 2018
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Kalexsyn, Inc., please visit www.kalexsyn.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.